Literature DB >> 15556136

Nitric oxide mediates cyclosporine-induced impairment of the blood-brain barrier in cocultures of mouse brain endothelial cells and rat astrocytes.

Shinya Dohgu1, Atsushi Yamauchi, Shinsuke Nakagawa, Fuyuko Takata, Mamiko Kai, Takashi Egawa, Mikihiko Naito, Takashi Tsuruo, Yasufumi Sawada, Masami Niwa, Yasufumi Kataoka.   

Abstract

The present study was designed to clarify the involvement of nitric oxide (NO) signaling in the adverse effect of cyclosporine on the blood-brain barrier. Cyclosporine increased the permeability of sodium-fluorescein and the cellular accumulation of rhodamine 123, a substrate of P-glycoprotein, in mouse brain endothelial (MBEC4) cells. This effect was markedly enhanced two- to threefold when MBEC4 cells were cocultured with rat astrocytes or C6 glioma cells. Direct and continuous electrochemical measurement of NO demonstrated that cyclosporine dose-dependently increased histamine- and phenylephrine-evoked NO production in MBEC4 cells and astrocytes, respectively. A NO synthase inhibitor (NG-monomethyl-L-arginine) blocked slightly and markedly cyclosporine-induced impairment of the endothelial barrier in the monolayer and coculture system, respectively. These findings suggest that cyclosporine impairs the brain endothelial barrier function by accelerating NO production in the brain endothelial and astroglial cells. This event may be interpreted as triggering the occurrence of cyclosporine neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556136     DOI: 10.1016/j.ejphar.2004.10.027

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Biphasic regulation of P-glycoprotein function and expression by NO donors in Caco-2 cells.

Authors:  Ru Duan; Nan Hu; Hai-yan Liu; Jia Li; Hai-fang Guo; Can Liu; Li Liu; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-04-30       Impact factor: 6.150

Review 2.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

Review 3.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

4.  Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro.

Authors:  Shinya Dohgu; Tsuyoshi Nishioku; Noriko Sumi; Fuyuko Takata; Shinsuke Nakagawa; Mikihiko Naito; Takashi Tsuruo; Atsushi Yamauchi; Hideki Shuto; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2007-10-13       Impact factor: 5.046

5.  Inhibition of transforming growth factor-beta production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-brain barrier.

Authors:  Fuyuko Takata; Shinya Dohgu; Atsushi Yamauchi; Noriko Sumi; Shinsuke Nakagawa; Mikihiko Naito; Takashi Tsuruo; Hideki Shuto; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2006-12-28       Impact factor: 4.231

Review 6.  Immunosuppression-related neurological disorders in kidney transplantation.

Authors:  Irene Faravelli; Daniele Velardo; Manuel Alfredo Podestà; Claudio Ponticelli
Journal:  J Nephrol       Date:  2021-01-22       Impact factor: 3.902

Review 7.  Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Zhuo Wang; Munan Zhao; Sujun Gao
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

8.  Protective effects of vascular endothelial growth factor in cultured brain endothelial cells against hypoglycemia.

Authors:  Fei Zhao; Jiangshan Deng; Xiaoyan Yu; Dawei Li; Hong Shi; Yuwu Zhao
Journal:  Metab Brain Dis       Date:  2015-03-13       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.